UBS Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,011
Closed -$161 10092
2022
Q4
$161 Sell
2,011
-95,888
-98% -$7.68K ﹤0.01% 9140
2022
Q3
$13K Buy
97,899
+89,346
+1,045% +$11.9K ﹤0.01% 7018
2022
Q2
$2K Sell
8,553
-110,119
-93% -$25.8K ﹤0.01% 8698
2022
Q1
$37K Buy
+118,672
New +$37K ﹤0.01% 5779
2021
Q4
Sell
-19,470
Closed -$45K 9727
2021
Q3
$45K Buy
+19,470
New +$45K ﹤0.01% 5324
2021
Q1
Sell
-4,812
Closed -$17K 8421
2020
Q4
$17K Sell
4,812
-2,586
-35% -$9.14K ﹤0.01% 6062
2020
Q3
$15K Buy
+7,398
New +$15K ﹤0.01% 5679
2019
Q4
Sell
-1,213
Closed -$1K 7288
2019
Q3
$1K Buy
+1,213
New +$1K ﹤0.01% 6911
2019
Q1
Sell
-5,981
Closed -$6K 7239
2018
Q4
$6K Buy
5,981
+3,925
+191% +$3.94K ﹤0.01% 6577
2018
Q3
$4K Buy
2,056
+686
+50% +$1.34K ﹤0.01% 6672
2018
Q2
$3K Sell
1,370
-2,560
-65% -$5.61K ﹤0.01% 6743
2018
Q1
$12K Buy
+3,930
New +$12K ﹤0.01% 5892
2017
Q4
Sell
-364
Closed -$1K 7051
2017
Q3
$1K Buy
364
+264
+264% +$725 ﹤0.01% 6685
2017
Q2
$0 Hold
100
﹤0.01% 6941
2017
Q1
$0 Sell
100
-2,086
-95% ﹤0.01% 6912
2016
Q4
$3K Buy
2,186
+991
+83% +$1.36K ﹤0.01% 6456
2016
Q3
$2K Buy
1,195
+1,095
+1,095% +$1.83K ﹤0.01% 6491
2016
Q2
$0 Sell
100
-1,379
-93% ﹤0.01% 6982
2016
Q1
$3K Buy
1,479
+56
+4% +$114 ﹤0.01% 6351
2015
Q4
$5K Buy
1,423
+1,241
+682% +$4.36K ﹤0.01% 6335
2015
Q3
$0 Sell
182
-6,124
-97% ﹤0.01% 7003
2015
Q2
$27K Buy
6,306
+5,751
+1,036% +$24.6K ﹤0.01% 5273
2015
Q1
$2K Sell
555
-1,548
-74% -$5.58K ﹤0.01% 6458
2014
Q4
$12K Buy
+2,103
New +$12K ﹤0.01% 5918